NutriBand (NTRB) Shareholder's Equity Growth (3y) (2019 - 2026)
NutriBand (NTRB) Shareholder's Equity Growth (3y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
NutriBand |
41.91 Mn |
37.33 Mn |
88,941.00 |
| Date | Value |
|---|
| Jan 31, 2026 |
-4.16% |
| Oct 31, 2025 |
-8.12% |
| Jul 31, 2025 |
-6.53% |
| Apr 30, 2025 |
-22.77% |
| Jan 31, 2025 |
-18.46% |
| Oct 31, 2024 |
-7.78% |
| Jul 31, 2024 |
19.42% |
| Apr 30, 2024 |
19.47% |
| Jan 31, 2024 |
-3.26% |
| Oct 31, 2023 |
-7.66% |
| Jul 31, 2023 |
74.51% |
| Apr 30, 2023 |
73.72% |
| Jan 31, 2023 |
265.60% |
| Oct 31, 2022 |
108.52% |
| Jul 31, 2022 |
85.37% |
| Apr 30, 2022 |
74.54% |
| Jan 31, 2022 |
70.22% |
| Oct 31, 2021 |
80.86% |
| Jul 31, 2021 |
35.99% |
| Apr 30, 2021 |
445.25% |
